New Zealand markets open in 2 hours 19 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.58-0.08 (-1.39%)
As of 03:41PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-115,266
-80,736
-71,038
-6,553
-155,636
Depreciation & amortisation
3,420
2,983
2,109
2,421
2,773
Stock-based compensation
21,231
17,825
16,964
14,977
7,531
Change in working capital
-17,918
-7,411
1,349
-2,901
1,175
Accounts receivable
-5,422
-4,854
-190
-8,883
-9,704
Inventory
-308
-331
-724
-49
-247
Accounts payable
1,251
583
-621
1,796
-452
Other working capital
-87,111
-76,321
-63,318
-66,744
-54,395
Other non-cash items
6,846
6,106
4,853
4,628
4,414
Net cash provided by operating activities
-84,148
-70,234
-59,603
-65,550
-53,554
Cash flows from investing activities
Investments in property, plant and equipment
-2,963
-6,087
-3,715
-1,194
-841
Net cash used for investing activities
-2,963
-6,087
-3,715
-1,194
-841
Cash flows from financing activities
Debt repayment
-26,125
-28,125
0
-4,167
-3,201
Common stock issued
433,614
117,261
0
0
224,682
Other financing activities
-
-5,184
-
-275
-
Net cash used provided by (used for) financing activities
490,973
169,828
1,454
2,851
228,014
Net change in cash
403,862
93,507
-61,864
-63,893
173,620
Cash at beginning of period
80,790
104,064
165,928
229,821
56,201
Cash at end of period
484,652
197,571
104,064
165,928
229,821
Free cash flow
Operating cash flow
-84,148
-70,234
-59,603
-65,550
-53,554
Capital expenditure
-2,963
-6,087
-3,715
-1,194
-841
Free cash flow
-87,111
-76,321
-63,318
-66,744
-54,395